/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-06-01 14:49:212025-02-03 12:08:00A Novel Investigational Treatment for Hypersomnia: Where We Are and Where We Need to Go
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-04-15 15:31:342025-02-03 12:08:01Arimoclomol in adults with NPC in a real-world setting: Long-term data from an expanded access program in the USA
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-10-04 16:09:522024-10-10 08:37:21Evaluation of the Long-Term Effect of Arimoclomol in NPC – 48 Months Data from CT-ORZY-NPC-002
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-10-04 16:01:232024-10-10 08:37:21Real World Data Collection in Niemann-Pick Disease Type C – Data from Expanded Access Program with Arimoclomol
/wp-content/uploads/logo.svg
0
0
eallison
/wp-content/uploads/logo.svg
eallison2023-09-08 14:02:352023-09-08 14:02:35Cardiovascular (CV) Safety and Pharmacokinetics (PK) of Serdexmethylphenidate (SDX), a Prodrug of d-Methylphenidate (d-MPH) Compared to Ritalin and Ritalin LA in a Single-Dose Crossover Study in Healthy Volunteers
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-07-03 09:13:102024-10-10 08:44:51Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-06-07 09:17:472023-07-03 11:27:43A Clinical Study with KP1077 in Adults with Idiopathic Hypersomnia
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-04-04 09:37:032024-10-10 08:32:23Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-04-04 09:34:302024-10-10 08:32:23Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
/wp-content/uploads/logo.svg
0
0
David Anderson
/wp-content/uploads/logo.svg
David Anderson2023-03-01 16:16:582024-10-10 08:32:23Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2/3 trial of a novel treatment
Scroll to top
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settings
Cookie and Privacy Settings